When Journalists Get Too Cozy with the Drug Industry

Aslı TUNÇ In the midst of the swine flu epidemic caused by H1N1 influenza virus, Novartis, a Swiss-based pharmaceutical company, invited a coterie of Turkish journalists to South Africa. The journalists from the dailies, Hürriyet, Radikal and Zaman enjoyed the “hospitality” of the drug company for three days in November. As ordinary readers we learned afterwards that Novartis had briefed them about the company’s “medical breakthroughs” in vaccination of malaria and tried to promote its products, activities and services in Africa. During the journalists’ trip to South Africa, not a single reporter or columnist asked a question on the company’s vaccination policies on swine flu or even mentioned the major pandemic hitting the world and Turkey. The Turkish journalists only indicated in their newspapers that they learned a lot about Novartis’s successes around the world and they got very impressed by the company’s activities. When asked on several TV channels, they declined to answer the question about who paid the expenses of the trip. This gave me a strong impression that this had been an all-expenses-paid trip. Also it made me wonder how many of the journalists in this country would have the courage and integrity to say no to those trips in the future.It is not surprising that pharmaceutical companies work really hard to get their message out to the public and physicians through advertisements. However, there are also well-known ethical guidelines on journalistic integrity and independence when it comes to expenses-paid trips unless they are the only way to cover a significant event. For instance, in BBC editorial guidelines, it indicates that journalists should avoid conflicts of interest, real or perceived, remain free of associations and activities that may compromise integrity or damage credibility and refuse gifts, favors, fees, free travel and special treatment, and shun secondary employment, […]
